Back to results

CompletedPhase 3

Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer

NCT00561119

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Ajou University University Hospital

Suwon, Gyeonggi-do, South Korea

+14 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2007-05
Enrollment: 326 participants
Sponsor: Samsung Medical Center
Purpose: treatment

Locations (15)

Ajou University University HospitalSuwon, Gyeonggi-do, South Korea
Hanlym University HospitalAnyang, Kyeongki-Do, South Korea
Bundang Seoul National University HospitalBundang, Kyeongki-Do, South Korea
Yeungnam University HospitalKyungsan, Kyungsangbuk-Do, South Korea
Daegu Patima HospitalDaegu, South Korea
Inha University School of MedicineInchon, South Korea
Seoul National University HospitalSeoul, South Korea
Yonsei University HospitalSeoul, South Korea
Samsung Medical CenterSeoul, South Korea
National Cancer CenterSeoul, South Korea
Kunkuk University HospitalSeoul, South Korea
Ewha University HospitalSeoul, South Korea
Asan Medical CenterSeoul, South Korea
Soonchunhyang University HospitalSeoul, South Korea
Ulsan University HospitalUlsan, South Korea

Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer — TrialFind